Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 12, Pages 3588
Publisher
MDPI AG
Online
2020-12-01
DOI
10.3390/cancers12123588
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic significance of PD‐L1 expression on cell‐surface vimentin‐positive circulating tumor cells in gastric cancer patients
- (2020) Mengyuan Liu et al. Molecular Oncology
- Epithelial‐mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1
- (2020) Baoguang Hu et al. Cancer Medicine
- Bring along your friends: Homotypic and heterotypic circulating tumor cell clustering to accelerate metastasis
- (2020) Nicola Aceto Biomedical Journal
- PD-L1 upregulation accompanied with epithelial–mesenchymal transition attenuates sensitivity to ATR inhibition in p53 mutant pancreatic cancer cells
- (2020) Na Song et al. MEDICAL ONCOLOGY
- Tracking cancer progression: from circulating tumor cells to metastasis
- (2020) Francesc Castro-Giner et al. Genome Medicine
- Strategies for enrichment of circulating tumor cells
- (2020) Xinchun Li et al. Translational Cancer Research
- Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes
- (2020) Clotilde Costa et al. Cancers
- Cell Surface Vimentin Positive Circulating Tumor Cell‐Based Relapse Prediction in a Long‐Term Longitudinal Study of Post‐Remission Neuroblastoma Patients
- (2020) Izhar S. Batth et al. INTERNATIONAL JOURNAL OF CANCER
- EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis
- (2020) Anthony Genna et al. Cancers
- Expression of PD-L1, cancer stem cell and epithelial–mesenchymal transition phenotype in non-small cell lung cancer
- (2020) Young Wha Koh et al. PATHOLOGY
- Circulating Tumor Cells With Epithelial–to–mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer
- (2019) MICHAL MEGO et al. ANTICANCER RESEARCH
- Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer
- (2019) Yen-Lin Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
- (2019) Chiara Agnoletto et al. Cancers
- Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking
- (2019) Brenda J. Green et al. ANALYTICAL CHEMISTRY
- CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients
- (2019) Yukun Sun et al. EBioMedicine
- Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
- (2019) Melanie Janning et al. Cancers
- PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer
- (2019) Yariswamy Manjunath et al. Cancers
- Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients
- (2019) Bianca C. Troncarelli Flores et al. Cells
- Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
- (2019) Lorena Incorvaia et al. ADVANCES IN THERAPY
- Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non–Small-Cell Lung Cancer
- (2019) Emma Pailler et al. CLINICAL CANCER RESEARCH
- Metastatic seeding of human colon cancer cell clusters expressing the hybrid epithelial/mesenchymal state
- (2019) Kosuke Mizukoshi et al. INTERNATIONAL JOURNAL OF CANCER
- Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment
- (2019) Ippokratis Messaritakis et al. LUNG CANCER
- Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer
- (2019) Ryon P. Graf et al. EUROPEAN UROLOGY
- Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer
- (2019) Ying Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion
- (2019) Yuanyuan Jiang et al. CANCER LETTERS
- PD‐L1 Expression on Circulating Tumor Cells May Be Predictive of Response to Pembrolizumab in Advanced Melanoma: Results from a Pilot Study
- (2019) Muhammad A. Khattak et al. ONCOLOGIST
- The Discordance of Gene Mutations between Circulating Tumor Cells and Primary/Metastatic Tumor
- (2019) Qi Wang et al. Molecular Therapy-Oncolytics
- Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial
- (2018) M Ignatiadis et al. ANNALS OF ONCOLOGY
- PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation
- (2018) Xin Yao Qiu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma
- (2018) Lu-Nan Qi et al. CANCER RESEARCH
- Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter
- (2018) Masaru Watanabe et al. CANCER SCIENCE
- Circulating Tumor Cells Correlate with Clinicopathological Features and Outcomes in Differentiated Thyroid Cancer
- (2018) Zhong-Ling Qiu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Change in Topoisomerase 1–Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol
- (2018) Hope S. Rugo et al. CLINICAL CANCER RESEARCH
- PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
- (2018) Nicolas Guibert et al. LUNG CANCER
- AR-V7 in circulating tumor cells cluster as a predictive biomarker of abiraterone acetate and enzalutamide treatment in castration-resistant prostate cancer patients
- (2018) Takatsugu Okegawa et al. PROSTATE
- Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamide
- (2018) Sumanta K. Pal et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Prognostic significance of circulating tumor microemboli in patients with pancreatic ductal adenocarcinoma
- (2018) Guangdong Wu et al. Oncology Letters
- Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis
- (2018) Wuyi Wang et al. CELLULAR ONCOLOGY
- Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)
- (2018) Young Kwang Chae et al. Scientific Reports
- Detection of Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells in Patients with Esophageal Squamous Carcinoma
- (2018) Dingpei Han et al. Biomed Research International
- Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses
- (2018) Liang-Chun Yin et al. Biomed Research International
- Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy
- (2018) Chunyan Yue et al. OncoImmunology
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor
- (2018) Elena Helman et al. Clinical Lung Cancer
- CD44+ cytokeratin-positive tumor cells in blood and bone marrow are associated with poor prognosis of patients with gastric cancer
- (2018) Antoni Szczepanik et al. Gastric Cancer
- Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment
- (2018) Ippokratis Messaritakis et al. LUNG CANCER
- A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer
- (2018) Tanya T. Kwan et al. Cancer Discovery
- Circulating glioma cells exhibit stem cell-like properties
- (2018) Tianrun Liu et al. CANCER RESEARCH
- Expression of AR-V7 and ARv567es in circulating tumor cells correlates with outcomes to taxane therapy in men with metastatic prostate cancer treated in TAXYNERGY
- (2018) Scott T Tagawa et al. CLINICAL CANCER RESEARCH
- Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer
- (2018) Maria A Papadaki et al. MOLECULAR CANCER THERAPEUTICS
- Epithelial‑mesenchymal transition phenotype of circulating tumor cells is associated with distant metastasis in patients with NSCLC
- (2018) Xiaochen Zhang et al. Molecular Medicine Reports
- EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients
- (2018) Sanne de Wit et al. Oncotarget
- Expression of immune-regulatory molecules in circulating tumor cells derived from patients with head and neck squamous cell carcinoma
- (2018) Kazuaki Chikamatsu et al. ORAL ONCOLOGY
- Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
- (2017) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer
- (2017) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood
- (2017) Zhong Wang et al. JOURNAL OF GASTROINTESTINAL SURGERY
- New insights into the role of EMT in tumor immune escape
- (2017) Stéphane Terry et al. Molecular Oncology
- Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response
- (2017) Wen-Wen Sun et al. OncoTargets and Therapy
- High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab
- (2017) Halin Bao et al. Oncology Letters
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
- (2017) Aadel A. Chaudhuri et al. Cancer Discovery
- Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients
- (2017) Shinsaku Togo et al. Oncotarget
- Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer
- (2017) Jennifer Podolak et al. Oncotarget
- EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy
- (2017) Issam Chebouti et al. Oncotarget
- EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression
- (2017) Arun Satelli et al. Oncotarget
- Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
- (2017) Birte Kulemann et al. Scientific Reports
- PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?
- (2017) Cristina Raimondi et al. OncoImmunology
- 1088PDLONG-TERM SURVIVAL OF IPILIMUMAB-NAïVE PATIENTS (PTS) WITH ADVANCED MELANOMA (MEL) TREATED WITH NIVOLUMAB (ANTI-PD-1; BMS-936558, ONO-4538) IN A PHASE 1 TRIAL
- (2017) D.F. McDermott et al. ANNALS OF ONCOLOGY
- The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial
- (2017) B. A. S. Jaeger et al. PLoS One
- Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
- (2016) Shaohua Zhang et al. BMC CANCER
- Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer
- (2016) C. R. Lindsay et al. BMC CANCER
- Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer
- (2016) Chun Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
- (2016) Y. Lou et al. CLINICAL CANCER RESEARCH
- Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery
- (2016) Jérôme Alexandre Denis et al. Molecular Oncology
- Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer
- (2016) Christin Gasch et al. Molecular Oncology
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters
- (2016) Kevin J. Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
- (2016) Chan-Young Ock et al. Oncotarget
- Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells
- (2016) Xiuwen Guan et al. Oncotarget
- Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer
- (2016) Ren Zhao et al. Oncotarget
- Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor
- (2016) Nick Beije et al. NEOPLASIA
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- Characterization of different CTC subpopulations in non-small cell lung cancer
- (2016) Annkathrin Hanssen et al. Scientific Reports
- Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients
- (2016) Arun Satelli et al. Scientific Reports
- Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
- (2016) Chiara Nicolazzo et al. Scientific Reports
- Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer
- (2015) M. Mego et al. BMC CANCER
- Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer
- (2015) Hara Polioudaki et al. BMC CANCER
- Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases
- (2015) Jie-Fu Chen et al. CANCER
- Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer
- (2015) Marcilei EC Buim et al. CANCER BIOLOGY & THERAPY
- Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses
- (2015) T. K. Sundaresan et al. CLINICAL CANCER RESEARCH
- A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
- (2015) M. P. Mak et al. CLINICAL CANCER RESEARCH
- Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer
- (2015) Sumanta K. Pal et al. Clinical Genitourinary Cancer
- The role of EMT and MET in cancer dissemination
- (2015) Jacqueline Banyard et al. CONNECTIVE TISSUE RESEARCH
- Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
- (2015) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients
- (2015) Nur-Afidah Mohamed Suhaimi et al. Molecular Oncology
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- Circulating Tumor Cells Found in Patients With Localized and Advanced Pancreatic Cancer
- (2015) Birte Kulemann et al. PANCREAS
- KRAS mutations in pancreatic circulating tumor cells: a pilot study
- (2015) Birte Kulemann et al. TUMOR BIOLOGY
- Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response
- (2015) Ting-Ting Li WORLD JOURNAL OF GASTROENTEROLOGY
- High-Density Dielectrophoretic Microwell Array for Detection, Capture, and Single-Cell Analysis of Rare Tumor Cells in Peripheral Blood
- (2015) Atsushi Morimoto et al. PLoS One
- Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
- (2014) Maria A Papadaki et al. BMC CANCER
- Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells
- (2014) Arun Satelli et al. CANCER RESEARCH
- Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
- (2014) Nicola Aceto et al. CELL
- Epithelial-Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression
- (2014) A. Satelli et al. CLINICAL CANCER RESEARCH
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Cell-surface Vimentin: A mislocalized protein for isolating csVimentin+CD133−novel stem-like hepatocellular carcinoma cells expressing EMT markers
- (2014) Abhisek Mitra et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
- (2014) Jeffrey B. Smerage et al. JOURNAL OF CLINICAL ONCOLOGY
- Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention
- (2014) Samantha Kaufhold et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
- (2014) Brigitte Rack et al. JNCI-Journal of the National Cancer Institute
- Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
- (2014) Lorena Alonso-Alconada et al. Molecular Cancer
- Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential
- (2014) Aleksandra Markiewicz et al. PLoS One
- Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment
- (2014) Antonio Marchetti et al. PLoS One
- KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer
- (2014) Aristea Kalikaki et al. PLoS One
- “Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
- (2014) Marius Ilie et al. PLoS One
- A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer
- (2014) T B Dorff et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Individual Profiling of Circulating Tumor Cell Composition and Therapeutic Outcome in Patients with Hepatocellular Carcinoma
- (2014) Ivonne Nel et al. Translational Oncology
- Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment
- (2014) Laura Muinelo-Romay et al. Cancers
- Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial
- (2013) F. C. Bidard et al. ANNALS OF ONCOLOGY
- Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM)
- (2013) Kazue Yoneda et al. ANNALS OF SURGICAL ONCOLOGY
- Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
- (2013) Francesco Fabbri et al. CANCER LETTERS
- Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non–Small-Cell Lung Cancer
- (2013) Emma Pailler et al. JOURNAL OF CLINICAL ONCOLOGY
- Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer
- (2013) Chun-Liang Chen et al. PROSTATE
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- (2013) M. Yu et al. SCIENCE
- Inertial Focusing for Tumor Antigen-Dependent and -Independent Sorting of Rare Circulating Tumor Cells
- (2013) E. Ozkumur et al. Science Translational Medicine
- Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis
- (2012) Guislaine Barrière et al. BMC CANCER
- Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
- (2012) L. Zhang et al. CLINICAL CANCER RESEARCH
- Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step
- (2012) Michael Herman Chui INTERNATIONAL JOURNAL OF CANCER
- KRASandBRAFmutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
- (2012) Bianca Mostert et al. INTERNATIONAL JOURNAL OF CANCER
- Association Between Circulating Tumor Cells and Prognosis in Patients With Stage III Melanoma With Sentinel Lymph Node Metastasis in a Phase III International Multicenter Trial
- (2012) Sojun Hoshimoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumour cells in non-metastatic breast cancer: a prospective study
- (2012) Anthony Lucci et al. LANCET ONCOLOGY
- Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer
- (2012) A. Giordano et al. MOLECULAR CANCER THERAPEUTICS
- Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors
- (2012) Edward H Cho et al. PHYSICAL BIOLOGY
- EMT as the ultimate survival mechanism of cancer cells
- (2012) Neha Tiwari et al. SEMINARS IN CANCER BIOLOGY
- Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation
- (2012) Michal Mego et al. Journal of Cancer
- Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
- (2011) Cristina Raimondi et al. BREAST CANCER RESEARCH AND TREATMENT
- Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
- (2011) A Lecharpentier et al. BRITISH JOURNAL OF CANCER
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
- (2011) Myriam Labelle et al. CANCER CELL
- Vimentin in cancer and its potential as a molecular target for cancer therapy
- (2011) Arun Satelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Prognostic Role of Twist, Slug, and Foxc2 Expression in Stage I Non–Small-Cell Lung Cancer After Curative Resection
- (2011) Wei Jiang et al. Clinical Lung Cancer
- Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal
- (2011) Angela Gradilone et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer
- (2011) Hisae Iinuma et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
- (2011) A. J. Armstrong et al. MOLECULAR CANCER RESEARCH
- Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis
- (2011) M A Smit et al. ONCOGENE
- HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
- (2010) Tanja Fehm et al. BREAST CANCER RESEARCH AND TREATMENT
- Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer
- (2010) L M Flores et al. BRITISH JOURNAL OF CANCER
- Epithelial–mesenchymal transition in the skin
- (2010) Motonobu Nakamura et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition
- (2010) Yvonne L Chao et al. Molecular Cancer
- Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
- (2010) S. L. Stott et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
- (2009) S. J. Aitken et al. ANNALS OF ONCOLOGY
- Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
- (2009) Panayiotis A. Theodoropoulos et al. CANCER LETTERS
- Epithelial-Mesenchymal Transition and Cell Cooperativity in Metastasis
- (2009) T. Tsuji et al. CANCER RESEARCH
- A Twist-Snail Axis Critical for TrkB-Induced Epithelial-Mesenchymal Transition-Like Transformation, Anoikis Resistance, and Metastasis
- (2009) M. A. Smit et al. MOLECULAR AND CELLULAR BIOLOGY
- Prognostic significance of hypoxia-inducible factor-1 , TWIST1 and Snail expression in resectable non-small cell lung cancer
- (2009) J-J Hung et al. THORAX
- Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer
- (2009) Seigo Nakamura et al. Breast Cancer
- Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance
- (2008) Stella Apostolaki et al. BREAST CANCER RESEARCH AND TREATMENT
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells
- (2008) Julie Douville et al. STEM CELLS AND DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started